609-55-2 Usage
Description
2-amino-5-methylbenzenesulfonamide, an organic compound with the molecular formula C7H10N2O2S, is a white crystalline solid that is sparingly soluble in water. It is commonly utilized as a pharmaceutical intermediate in the synthesis of various medications, particularly sulfonamide drugs. This chemical possesses antibacterial properties and is being explored for its potential in treating urinary tract infections and developing antitumor agents.
Uses
Used in Pharmaceutical Industry:
2-amino-5-methylbenzenesulfonamide is used as a pharmaceutical intermediate for the synthesis of sulfonamide drugs, which are known for their antibacterial properties. It plays a crucial role in the development of medications that combat bacterial infections.
Used in Urinary Tract Infections Treatment:
In the medical field, 2-amino-5-methylbenzenesulfonamide is being studied for its potential use in treating urinary tract infections. Its antibacterial properties make it a promising candidate for this application.
Used in Antitumor Agent Development:
2-amino-5-methylbenzenesulfonamide is also being investigated for its potential in the development of antitumor agents. Its properties are being explored to contribute to the creation of medications that can help in the fight against cancer.
Safety Precautions:
It is important to handle 2-amino-5-methylbenzenesulfonamide with care, as it may be harmful if ingested or inhaled, and can cause skin and eye irritation. Proper safety measures should be taken during its use to minimize any potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 609-55-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,0 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 609-55:
(5*6)+(4*0)+(3*9)+(2*5)+(1*5)=72
72 % 10 = 2
So 609-55-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N2O2S/c1-5-2-3-6(8)7(4-5)12(9,10)11/h2-4H,8H2,1H3,(H2,9,10,11)
609-55-2Relevant articles and documents
Effect of C7 Modifications on Benzothiadiazine-1,1-dioxide Derivatives on Their Inhibitory Activity and Selectivity toward Aldose Reductase
Zhang, Shuzhen,Chen, Xin,Parveen, Shagufta,Hussain, Saghir,Yang, Yanchun,Jing, Chaojun,Zhu, Changjin
, p. 603 - 613 (2013/08/22)
The development and progression of chronic complications in diabetic patients, such as retinopathy, nephropathy, neuropathy, cataracts, and stroke, are related to the activation and/or overexpression of aldose reductase (ALR2), which is a member of the al
METHODS FOR IDENTIFICATION OF JAK KINASE INTERACTING MOLECULES AND FOR THE PURIFICATION OF JAK KINASES
-
Page/Page column 35-36, (2009/06/27)
The present invention relates to immobilization compounds and methods useful for the identification of JAK interacting compounds or for the purification or identification of JAK.
Inhibitors of HCV NS5B polymerase: Synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring
Rockway, Todd W.,Zhang, Rong,Liu, Dachun,Betebenner, David A.,McDaniel, Keith F.,Pratt, John K.,Beno, David,Montgomery, Debra,Jiang, Wen W.,Masse, Sherie,Kati, Warren M.,Middleton, Tim,Molla, Akhteruzzaman,Maring, Clarence J.,Kempf, Dale J.
, p. 3833 - 3838 (2007/10/03)
A series of non-nucleoside HCV NS5B polymerase inhibitors based on the N-1-benzyl or N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine core substituted in the D-ring aromatic moiety have been prepared and evaluated. Aromatic substituents extending from position 7 of the D-ring exhibited excellent potency against both genotypes 1a and 1b.
